0001070081-17-000053.txt : 20170217 0001070081-17-000053.hdr.sgml : 20170217 20170217181424 ACCESSION NUMBER: 0001070081-17-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170216 FILED AS OF DATE: 20170217 DATE AS OF CHANGE: 20170217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rothera Mark CENTRAL INDEX KEY: 0001550424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 17622814 MAIL ADDRESS: STREET 1: C/O AEGERION PHARMACEUTICALS, INC. STREET 2: 101 MAIN STREET, SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_148737325111545.xml FORM 4 X0306 4 2017-02-16 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001550424 Rothera Mark C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Commercial Officer Common Stock 2017-02-16 4 M 0 3125 10.85 A 28773 D Common Stock 9216 I By Trust Stock Option (Right To Buy) 10.85 2017-02-16 4 M 0 3125 0 D 2023-05-15 Common Stock 3125.0 72193 D Stock Option (Right To Buy) 10.85 2023-05-15 Common Stock 8125.0 8125 D Stock Option (Right To Buy) 27.05 2024-01-27 Common Stock 65000.0 65000 D Stock Option (Right To Buy) 51.0 2025-01-01 Common Stock 69550.0 69550 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 70000.0 70000 D Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 56000.0 56000 D Shares held by trust of which reporting person's spouse is a beneficiary and co-trustee. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. This option was granted on May 15, 2013 and vests as follows: 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014. This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015. This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. /s/ Colleen Diver Johnson, attorney-in-fact 2017-02-17